Artículos de revistas sobre el tema "Broadly neutralizing antibodies (bNAbs)"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Broadly neutralizing antibodies (bNAbs)".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Karuna, Shelly T. y Lawrence Corey. "Broadly Neutralizing Antibodies for HIV Prevention". Annual Review of Medicine 71, n.º 1 (27 de enero de 2020): 329–46. http://dx.doi.org/10.1146/annurev-med-110118-045506.
Texto completoYang, Guang, Mengfei Liu, Kevin Wiehe, Nathan Nicely, Barton Haynes, John Mascola, Pamela Bjorkman y Garnett Kelsoe. "HIV broadly neutralizing antibodies and immunological tolerance (VAC7P.988)". Journal of Immunology 192, n.º 1_Supplement (1 de mayo de 2014): 141.33. http://dx.doi.org/10.4049/jimmunol.192.supp.141.33.
Texto completoLubow, Jay, Lisa M. Levoir, Duncan K. Ralph, Laura Belmont, Maya Contreras, Catiana H. Cartwright-Acar, Caroline Kikawa et al. "Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses". PLOS Pathogens 19, n.º 10 (9 de octubre de 2023): e1011722. http://dx.doi.org/10.1371/journal.ppat.1011722.
Texto completoSprenger, Kayla G., Joy E. Louveau, Pranav M. Murugan y Arup K. Chakraborty. "Optimizing immunization protocols to elicit broadly neutralizing antibodies". Proceedings of the National Academy of Sciences 117, n.º 33 (3 de agosto de 2020): 20077–87. http://dx.doi.org/10.1073/pnas.1919329117.
Texto completoGlazkova, D. V., E. V. Bogoslovskaya, G. A. Shipulin y S. M. Yudin. "Broadly neutralizing antibodies for the treatment of HIV infection". HIV Infection and Immunosuppressive Disorders 13, n.º 3 (24 de octubre de 2021): 81–95. http://dx.doi.org/10.22328/2077-9828-2021-13-3-81-95.
Texto completoShrader, Hannah, Sabrina Helmold Hait, Sarah Lovelace, Meaghan Kilner, Chen-Hsiang Shen, Emily Coates, Martin Gaudinski et al. "Phenotypic analysis of HIV-1 resistance to CD4 binding site broadly-neutralizing antibodies". Journal of Immunology 210, n.º 1_Supplement (1 de mayo de 2023): 223.08. http://dx.doi.org/10.4049/jimmunol.210.supp.223.08.
Texto completoSteichen, Jon M., Ying-Cing Lin, Colin Havenar-Daughton, Simone Pecetta, Gabriel Ozorowski, Jordan R. Willis, Laura Toy et al. "A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses". Science 366, n.º 6470 (31 de octubre de 2019): eaax4380. http://dx.doi.org/10.1126/science.aax4380.
Texto completoThavarajah, Jannifer Jasmin, Bo Langhoff Hønge y Christian Morberg Wejse. "The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention". Viruses 16, n.º 6 (4 de junio de 2024): 911. http://dx.doi.org/10.3390/v16060911.
Texto completoKumar, Rajesh, Huma Qureshi, Suprit Deshpande y Jayanta Bhattacharya. "Broadly neutralizing antibodies in HIV-1 treatment and prevention". Therapeutic Advances in Vaccines and Immunotherapy 6, n.º 4 (agosto de 2018): 61–68. http://dx.doi.org/10.1177/2515135518800689.
Texto completoXu, Ling, Amarendra Pegu, Ercole Rao, Nicole Doria-Rose, Jochen Beninga, Krisha McKee, Dana M. Lord et al. "Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques". Science 358, n.º 6359 (20 de septiembre de 2017): 85–90. http://dx.doi.org/10.1126/science.aan8630.
Texto completoMayer, Bryan T., Allan C. deCamp, Yunda Huang, Joshua T. Schiffer, Raphael Gottardo, Peter B. Gilbert y Daniel B. Reeves. "Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention". PLOS Computational Biology 18, n.º 4 (6 de abril de 2022): e1010003. http://dx.doi.org/10.1371/journal.pcbi.1010003.
Texto completoKhurana, Surender, Megan Hahn, Laura Klenow y Hana Golding. "Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins". Viruses 12, n.º 10 (8 de octubre de 2020): 1140. http://dx.doi.org/10.3390/v12101140.
Texto completoSmith, S. Abigail y Cynthia A. Derdeyn. "Harnessing the protective potential of HIV-1 neutralizing antibodies". F1000Research 5 (5 de enero de 2016): 20. http://dx.doi.org/10.12688/f1000research.7254.1.
Texto completoMishra, Nitesh, Sanjeev Kumar, Swarandeep Singh, Tanu Bansal, Nishkarsh Jain, Sumedha Saluja, Rajesh Kumar et al. "Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma". PLOS Pathogens 17, n.º 9 (24 de septiembre de 2021): e1009958. http://dx.doi.org/10.1371/journal.ppat.1009958.
Texto completoMcGuire, Andrew T., Sam Hoot, Anita M. Dreyer, Adriana Lippy, Andrew Stuart, Kristen W. Cohen, Joseph Jardine et al. "Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies". Journal of Experimental Medicine 210, n.º 4 (25 de marzo de 2013): 655–63. http://dx.doi.org/10.1084/jem.20122824.
Texto completoMedina-Ramírez, Max, Fernando Garces, Amelia Escolano, Patrick Skog, Steven W. de Taeye, Ivan Del Moral-Sanchez, Andrew T. McGuire et al. "Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo". Journal of Experimental Medicine 214, n.º 9 (28 de agosto de 2017): 2573–90. http://dx.doi.org/10.1084/jem.20161160.
Texto completoAn, Zhiyin, Yu Zhang, Xiang Yu, Jia Xia, Yanan Yin, Guoming Li, Jing Lu, Xuemei Fan y Yingjie Xu. "The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice". Pharmaceutics 15, n.º 5 (5 de mayo de 2023): 1412. http://dx.doi.org/10.3390/pharmaceutics15051412.
Texto completoNoailly, Blandine, Melyssa Yaugel-Novoa, Justine Werquin, Fabienne Jospin, Daniel Drocourt, Thomas Bourlet, Nicolas Rochereau y Stéphane Paul. "Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent". Vaccines 10, n.º 6 (6 de junio de 2022): 903. http://dx.doi.org/10.3390/vaccines10060903.
Texto completoCaillat, Christophe, Delphine Guilligay, Guidenn Sulbaran y Winfried Weissenhorn. "Neutralizing Antibodies Targeting HIV-1 gp41". Viruses 12, n.º 11 (23 de octubre de 2020): 1210. http://dx.doi.org/10.3390/v12111210.
Texto completoSakoi-Mosetlhi, Maureen, Gbolahan Ajibola, Roxanna Haghighat, Oganne Batlang, Kenneth Maswabi, Molly Pretorius-Holme, Kathleen M. Powis et al. "Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART". PLOS ONE 19, n.º 3 (27 de marzo de 2024): e0299942. http://dx.doi.org/10.1371/journal.pone.0299942.
Texto completoWasilewski, Lisa N., Ramy El-Diwany, Supriya Munshaw, Anna E. Snider, Jillian K. Brady, William O. Osburn, Stuart C. Ray y Justin R. Bailey. "A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies". Journal of Virology 90, n.º 7 (27 de enero de 2016): 3773–82. http://dx.doi.org/10.1128/jvi.02837-15.
Texto completoStephenson, Kathryn E., Kshitij Wagh, Bette Korber y Dan H. Barouch. "Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention". Annual Review of Immunology 38, n.º 1 (26 de abril de 2020): 673–703. http://dx.doi.org/10.1146/annurev-immunol-080219-023629.
Texto completoAli, Ayub, Scott G. Kitchen, Irvin S. Y. Chen, Hwee L. Ng, Jerome A. Zack y Otto O. Yang. "HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies". Journal of Virology 90, n.º 15 (25 de mayo de 2016): 6999–7006. http://dx.doi.org/10.1128/jvi.00805-16.
Texto completoWelles, Hugh C., Hannah A. D. King, Leonard Nettey, Nicole Cavett, Jason Gorman, Tongqing Zhou, Yaroslav Tsybovsky et al. "Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4". PLOS Pathogens 18, n.º 6 (16 de junio de 2022): e1010574. http://dx.doi.org/10.1371/journal.ppat.1010574.
Texto completoBrinkkemper, Mitch y Kwinten Sliepen. "Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies". Vaccines 7, n.º 3 (29 de julio de 2019): 76. http://dx.doi.org/10.3390/vaccines7030076.
Texto completoKlein, Florian, Lilian Nogueira, Yoshiaki Nishimura, Ganesh Phad, Anthony P. West, Ariel Halper-Stromberg, Joshua A. Horwitz et al. "Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants". Journal of Experimental Medicine 211, n.º 12 (10 de noviembre de 2014): 2361–72. http://dx.doi.org/10.1084/jem.20141050.
Texto completoLingwood, Daniel. "Natural gene-encoded affinity for cognate antigen facilitates vaccine-amplification of broadly neutralizing antibodies against influenza virus". Journal of Immunology 202, n.º 1_Supplement (1 de mayo de 2019): 139.22. http://dx.doi.org/10.4049/jimmunol.202.supp.139.22.
Texto completoDoores, Katie J., Leopold Kong, Stefanie A. Krumm, Khoa M. Le, Devin Sok, Uri Laserson, Fernando Garces, Pascal Poignard, Ian A. Wilson y Dennis R. Burton. "Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope". Journal of Virology 89, n.º 2 (5 de noviembre de 2014): 1105–18. http://dx.doi.org/10.1128/jvi.02905-14.
Texto completoShcherbakov, D. N., A. Yu Bakulina, L. I. Karpenko y A. A. Ilyichev. "Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response". Acta Naturae 7, n.º 4 (15 de diciembre de 2015): 11–21. http://dx.doi.org/10.32607/20758251-2015-7-4-11-21.
Texto completoBiswas, Mrityunjoy, Tatsuya Yamazaki, Joe Chiba y Sachiko Akashi-Takamura. "Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination". Vaccines 8, n.º 3 (29 de julio de 2020): 424. http://dx.doi.org/10.3390/vaccines8030424.
Texto completoWang, Qian y Linqi Zhang. "Broadly neutralizing antibodies and vaccine design against HIV-1 infection". Frontiers of Medicine 14, n.º 1 (19 de diciembre de 2019): 30–42. http://dx.doi.org/10.1007/s11684-019-0721-9.
Texto completoDoria-Rose, Nicole A., Jinal N. Bhiman, Ryan S. Roark, Chaim A. Schramm, Jason Gorman, Gwo-Yu Chuang, Marie Pancera et al. "New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency". Journal of Virology 90, n.º 1 (14 de octubre de 2015): 76–91. http://dx.doi.org/10.1128/jvi.01791-15.
Texto completovan Dongen, Maria J. P., Rameshwar U. Kadam, Jarek Juraszek, Edward Lawson, Boerries Brandenburg, Frederike Schmitz, Wim B. G. Schepens et al. "A small-molecule fusion inhibitor of influenza virus is orally active in mice". Science 363, n.º 6431 (7 de marzo de 2019): eaar6221. http://dx.doi.org/10.1126/science.aar6221.
Texto completoMalbec, Marine, Françoise Porrot, Rejane Rua, Joshua Horwitz, Florian Klein, Ari Halper-Stromberg, Johannes F. Scheid et al. "Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission". Journal of Experimental Medicine 210, n.º 13 (25 de noviembre de 2013): 2813–21. http://dx.doi.org/10.1084/jem.20131244.
Texto completoTian, Ming, Kelly McGovern, Hwei-Ling Cheng, Peyton Waddicor, Lisa Rieble, Mai Dao, Yiwei Chen et al. "Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models". Proceedings of the National Academy of Sciences 117, n.º 14 (24 de marzo de 2020): 7929–40. http://dx.doi.org/10.1073/pnas.1921996117.
Texto completoVanderVeen, Laurie A., Lisa Selzer, Brian Moldt, Aiyappa Parvangada, Jiani Li, Jintanat Ananworanich, Trevor A. Crowell et al. "HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection". AIDS 38, n.º 4 (16 de noviembre de 2023): 607–10. http://dx.doi.org/10.1097/qad.0000000000003792.
Texto completoLiu, Mengfei, Guang Yang, Kevin Wiehe, Nathan I. Nicely, Nathan A. Vandergrift, Wes Rountree, Mattia Bonsignori et al. "Polyreactivity and Autoreactivity among HIV-1 Antibodies". Journal of Virology 89, n.º 1 (29 de octubre de 2014): 784–98. http://dx.doi.org/10.1128/jvi.02378-14.
Texto completoDiLillo, David, Gene Tan, Peter Palese y Jeffrey Ravetch. "Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo (VAC6P.951)". Journal of Immunology 192, n.º 1_Supplement (1 de mayo de 2014): 140.12. http://dx.doi.org/10.4049/jimmunol.192.supp.140.12.
Texto completoMkhize, Nonhlanhla N., Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume, David Matten et al. "Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials". PLOS Pathogens 19, n.º 6 (29 de junio de 2023): e1011469. http://dx.doi.org/10.1371/journal.ppat.1011469.
Texto completoSwann, Rachael E., Vanessa M. Cowton, Mark W. Robinson, Sarah J. Cole, Stephen T. Barclay, Peter R. Mills, Emma C. Thomson, John McLauchlan y Arvind H. Patel. "Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection". Journal of Virology 90, n.º 9 (24 de febrero de 2016): 4530–43. http://dx.doi.org/10.1128/jvi.02669-15.
Texto completoMankowski, Madeleine C., Valerie J. Kinchen, Lisa N. Wasilewski, Andrew I. Flyak, Stuart C. Ray, James E. Crowe y Justin R. Bailey. "Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms". Proceedings of the National Academy of Sciences 115, n.º 1 (18 de diciembre de 2017): E82—E91. http://dx.doi.org/10.1073/pnas.1718441115.
Texto completoWalsh, Stephen R. y Michael S. Seaman. "Broadly Neutralizing Antibodies for HIV-1 Prevention". Frontiers in Immunology 12 (20 de julio de 2021). http://dx.doi.org/10.3389/fimmu.2021.712122.
Texto completoLorenzi, Julio C. C., Pilar Mendoza, Yehuda Z. Cohen, Lilian Nogueira, Christy Lavine, Joseph Sapiente, Marie Wiatr et al. "Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates". Journal of Virology, 9 de diciembre de 2020. http://dx.doi.org/10.1128/jvi.01909-20.
Texto completoAnthony, Colin, Talita York, Valerie Bekker, David Matten, Philippe Selhorst, Roux-Cil Ferreria, Nigel J. Garrett et al. "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope". Journal of Virology 91, n.º 18 (5 de julio de 2017). http://dx.doi.org/10.1128/jvi.00828-17.
Texto completoWaters, Laura, Rosa de Miguel-Buckley, Sébastien Poulin y Jose R. Arribas. "Broadly Neutralizing Antibodies for HIV Treatment: Broad in Theory, Narrow in Reality". Clinical Infectious Diseases, 28 de octubre de 2022. http://dx.doi.org/10.1093/cid/ciac835.
Texto completoLeggat, David J., Kristen W. Cohen, Jordan R. Willis, William J. Fulp, Allan C. deCamp, Oleksandr Kalyuzhniy, Christopher A. Cottrell et al. "Vaccination induces HIV broadly neutralizing antibody precursors in humans". Science 378, n.º 6623 (2 de diciembre de 2022). http://dx.doi.org/10.1126/science.add6502.
Texto completoSchiffner, Torben, Ivy Phung, Rashmi Ray, Adriana Irimia, Ming Tian, Olivia Swanson, Jeong Hyun Lee et al. "Vaccination induces broadly neutralizing antibody precursors to HIV gp41". Nature Immunology, 30 de mayo de 2024. http://dx.doi.org/10.1038/s41590-024-01833-w.
Texto completoSpencer, David A., Mariya B. Shapiro, Nancy L. Haigwood y Ann J. Hessell. "Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic". Frontiers in Public Health 9 (26 de mayo de 2021). http://dx.doi.org/10.3389/fpubh.2021.690017.
Texto completoHsu, Denise C., John W. Mellors y Sandhya Vasan. "Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?" Frontiers in Immunology 12 (12 de julio de 2021). http://dx.doi.org/10.3389/fimmu.2021.710044.
Texto completoHuang, Deli, Jenny Tuyet Tran, Alex Olson, Thomas Vollbrecht, Mary Tenuta, Mariia V. Guryleva, Roberta P. Fuller et al. "Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells". Nature Communications 11, n.º 1 (17 de noviembre de 2020). http://dx.doi.org/10.1038/s41467-020-19650-8.
Texto completo